Ahmed, N., Wesson, W., Mushtaq, M. U., Bansal, R., AbdelHakim, H., Bromert, S., . . . Shune, L. (2023). “Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy. Frontiers Media S.A.
Chicago Style (17th ed.) CitationAhmed, Nausheen, et al. “Waitlist Mortality” Is High for Myeloma Patients with Limited Access to BCMA Therapy. Frontiers Media S.A, 2023.
MLA (9th ed.) CitationAhmed, Nausheen, et al. “Waitlist Mortality” Is High for Myeloma Patients with Limited Access to BCMA Therapy. Frontiers Media S.A, 2023.
Warning: These citations may not always be 100% accurate.